Prognosis of immune checkpoint inhibitor-induced myasthenia gravis: a single center experience and systematic review

Prognosis of immune checkpoint inhibitor-induced myasthenia gravis: a single center experience and systematic review

BackgroundImmune checkpoint inhibitors (ICI)-induced myasthenia gravis (MG) is an uncommon but potentially fatal neurotoxicity. We aim to help physicians familiarize themselves with the clinical characteristics of ICI-induced MG, facilitating early diagnosis and prompt intervention.MethodsWe searche...

Full description

Bibliographic Details
Main Authors: Yuhui Qin, Siyuan Chen, Qian Gui, Teng Zhang, Yanan Li, Zhijuan Du, Yahui Lv, Xiangyu Du, Yi Hu, Zhefeng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Neurology
Subjects:
myasthenia gravis
immune checkpoint inhibitors
immunotherapy
immune-related adverse events
neurotoxicity
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1372861/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1372861/full

Similar Items